Henry Schein Inc (HSIC)
Healthcare
Medical Distribution
85.80 $
+0.7%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Henry Schein Inc (HSIC)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 82.4% of the shares are freely tradable; institutional investors hold 108.5%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
108.5%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
0.8%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
82.4%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
8.1%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
114Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Kohlberg Kravis Roberts & Co LP | 13.74 | 15,652,032 | +0.0 | 03/31/2026 |
| Vanguard Group Inc | 10.17 | 11,588,199 | -3.4 | 12/31/2025 |
| BlackRock Inc | 6.17 | 7,022,989 | +0.9 | 03/31/2026 |
| Artisan Partners Limited Partnership | 5.77 | 6,573,023 | -1.1 | 03/31/2026 |
| Vanguard Capital Management, LLC | 5.64 | 6,423,167 | +0.0 | 03/31/2026 |
| FMR Inc | 5.02 | 5,722,149 | +44.0 | 03/31/2026 |
| Amvescap Plc. | 4.29 | 4,886,483 | +9.7 | 03/31/2026 |
| JPMorgan Chase & Co | 4.01 | 4,562,512 | -10.6 | 03/31/2026 |
| State Street Corp | 3.84 | 4,378,981 | -0.5 | 03/31/2026 |
| Vanguard Portfolio Management, LLC | 3.68 | 4,194,920 | +0.0 | 03/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.